Latest Articles
Exploiting Epigenetics in Cancer Treatment
ArticleChanges to the complex of DNA and the proteins that form chromatin are important drivers in many cancers. We explore the challenges and progress in the development of new therapies targeting epigenetic regulators.
READ MORE
Through the Looking Glass of Single Cell Proteomics
ArticleTo pick apart the differences between individual cells in complex multicellular organisms, we need to look at cells one-by-one. This article takes a look at how several scientists in North America are using single cell proteomics (SCP) technologies to discern disease pathogenesis and enhance directed stem-cell differentiation.
READ MORE
Chemical Snapshots and Molecular Maps with Mass Spec Imaging
ArticleMass spectrometry imaging (MSI) is a powerful tool increasingly being used in many fields including cancer research, biomarker discovery and drug development. This article explains why MSI is the technique of choice in many labs, discusses its use in research, and covers how some inherent challenges are being addressed.
READ MORE
Cancers of the Lung and the Rise of Artificial Intelligence
ArticleArtificial intelligence (AI) has begun to transform the world of healthcare and researchers across the globe are now dedicated to discovering its potential. This technology has particularly struck a chord with cancer research surrounding early detection, a long-standing concern for the cancer community.
READ MORE
Lab Automation Increases Repeatability, Reduces Errors in Drug Development
ArticleNew technologies are driving laboratory automation to improve efficiency, shorten time to FDA approval and reduce the number of technicians needed in the lab – driving overall development costs down.
READ MORE
Three Ways to Turn Life Science Suppliers into Partners
ArticleA growing number of life science businesses are turning to greater supply chain collaboration for benefits like accelerated time to market, improved quality, reduced risk and more rapid and widespread innovation. But while 68% of executives in this industry say active and meaningful engagement with suppliers is essential to success, far too many, over a third, struggle to implement it.
READ MORE
Deciphering the Cancer Proteome
ArticleThis article explores the current state of play within the area of cancer proteomics, highlights some of the techniques used to investigate the proteome, and looks at the impact of combining proteomics with other ‘omics’ in relation to cancer research.
READ MORE
Cancer Cells vs Normal Cells
ArticleCancer is a complex genetic disease that is caused by specific changes to the genes in one cell or group of cells. These changes disrupt normal cell function – specifically affecting how a cell grows and divides. This article outlines some of the key differences between cancer cells and normal cells.
READ MORE
Epigenetics and Drug Discovery
ArticleThis article aims to highlight the key types of epigenetic modification, summarize current and emerging drug discovery efforts to target epigenetic dysregulation and will discuss some of the benefits and challenges of epigenetic therapeutics.
READ MORE
One-Way vs Two-Way ANOVA: Differences, Assumptions and Hypotheses
ArticleA key statistical test in research fields including biology, economics and psychology, Analysis of Variance (ANOVA) is very useful for analyzing datasets. It allows comparisons to be made between three or more groups of data. Here, we summarize the key differences between these two tests, including the assumptions and hypotheses that must be made about each type of test.
READ MORE
